Table 3.

Percent body fat loss after sibutramine treatment by ADIPOQ genotype

	Sibutramine	Placebo	P valuea
CC	4.6% ± 0.5%	1.9% ± 0.3%	<0.001
GG	3.5% ± 0.6%	1.8% ± 0.4%	0.383
GC	3.2% ± 0.4%	3.0% ± 0.3%	0.814

Data are presented as mean ± standard deviation (adjusted for covariates from ANCOVA analyses).

^aP values are based on ANCOVA models.

Abbreviation: ADIPOQ, adiponectin C1Q and collagen domain containing.